Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Comparative Effectiveness Research Toolkit

The establishment of the nonprofit, public-private entity, the Patient-Centered Outcomes Research Institute (PCORI), in the new health reform law has elevated the visibility and importance of comparative effectiveness research (CER) in the health care system. But as CER takes on an increasingly influential role in informing coverage decisions and the treatments that patients receive, many questions remain about how to ensure that the comparative evidence that is developed is both scientifically valid and communicated in such a way that it can be applied appropriately.

To help you and your colleagues understand CER and some of the important questions under discussion, the National Pharmaceutical Council has developed this Comparative Effectiveness Research Tool Kit.

This CER Tool Kit includes the following materials:

Additional copies of the materials can be ordered through NPC’s website.

Blog Post

CER Tweets of the Week: All Things Patient (August 11-15)

This week’s comparative effectiveness research (CER) tweets revolve around patient-centric news. The Patient-Centered Outcomes Research Institute’s (...
Blog Post

CER Tweets of the Week: Will CER Really Deliver Better Patient Outcomes? (August 4-8)

Comparative effectiveness research (CER) stakeholders shared news about the Patient-Centered Outcomes Research Institute’s next funding round with...
Press Release

Michael Ciarametaro Joins National Pharmaceutical Council as Director of Research

WASHINGTON, DC (July 31, 2014)—The National Pharmaceutical Council (NPC) today announced that Michael Ciarametaro has joined the health policy...
Newsletter Volume

E.V.I.dently July 2014

NPC MessageWhen & How Health Decision-Makers Should Consider Individual Patient DifferencesBy Jennifer S. Graff, PharmD, NPC Director of...
Press Release

Michael Ciarametaro Joins National Pharmaceutical Council as Director of Research

WASHINGTON, DC (July 31, 2014)—The National Pharmaceutical Council (NPC) today announced that Michael Ciarametaro has joined the health policy...
Press Release

NPC Study Outlines When & How Health Decision-Makers Should Consider Individual Patient Differences

Washington, DC (July 29, 2014)—New research led by the National Pharmaceutical Council (NPC) can assist health care stakeholders to understand when...
Press Release

NPC Annual Stakeholder Survey: Comparative Effectiveness Research Is Important, But Impact on Health Care Decision-Making Is Still on the Horizon

(Washington, DC, May 19, 2014)—A new survey of health care stakeholders reveals continued optimism for the use of comparative effectiveness research...
Press Release

CER Collaborative Improving Health Outcomes Through New Comparative Evidence Tools

(Washington, DC, March 24, 2014)—Three peer-reviewed articles published in Value in Health offer important guidance to aid formulary decision-makers...
Commentary and Testimony Page

NPC Comments on CMS' Proposed Changes to Protected Classes

March 7, 2014Marilyn B. TavennerAdministratorCenters for Medicare & Medicaid ServicesU.S. Department of Health and Human Services200 Independence...
Commentary and Testimony Page

The State of CER and the Environment for Health Care Decision Making

This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (CER), “The State of Comparative...
Commentary and Testimony Page

Keeping Our Eye on the CER Ball

Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington will focus on the federal budget....
Commentary and Testimony Page

Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?

A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...
YouTube Videos

Real-World Impact of Comparative Effectiveness Research Findings on Clinical Practice

National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, discusses a peer-reviewed study suggesting that changes are needed...
YouTube Videos

CER and the Environment for Health Care Decision-Making

The National Pharmaceutical Council’s (NPC) fourth annual survey of health care stakeholders is continuing to shed light on the current environment...
YouTube Videos

Webinar: CER Collaborative: Tools You Can Use

Collaborative members hosted a webinar explaining how to use the tools they developed to create greater uniformity and transparency when evaluating...
YouTube Videos

Use of Big and Real-World Data by Pharma: More than Data Warehousing

Real-world data—a subset of big data—is clinical data used for decision-making that did not come from a clinical trial. According to Aaron Galaznik,...
Blog Post

CER Tweets of the Week: All Things Patient (August 11-15)

This week’s comparative effectiveness research (CER) tweets revolve around patient-centric news. The Patient-Centered Outcomes Research Institute’s (...
Blog Post

CER Tweets of the Week: Will CER Really Deliver Better Patient Outcomes? (August 4-8)

Comparative effectiveness research (CER) stakeholders shared news about the Patient-Centered Outcomes Research Institute’s next funding round with...
Blog Post

PCORI Grants, HEOR & FDA Guidance Top CER Tweets of the Week (July 21-25)

What were some of the popular comparative effectiveness research (CER)-related topics on Twitter this week? We saw keen interest in the Patient-...
Blog Post

#TBT: Expanding Your Horizons: CER Continuing Education Certificate Program

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...

Research

  •  
  • 1 of 23
  • >

Commentary & Testimony